Genes implicated in late-onset Alzheimer's disease

11 new genetic susceptibility factors for Alzheimer’s identified

The largest international study ever conducted on Alzheimer's disease (I-GAP) has identified 11 new genetic regions that increase the risk of late-onset Alzheimer’s, plus 13 other genes yet to be validated. Genetic data came from 74,076 patients and controls from 15 countries.

Eleven genes for Alzheimer's disease have previously been identified.

Some of the newly associated genes confirm biological pathways already known to be involved, including the amyloid (SORL1, CASS4 ) and tau (CASS4 , FERMT2 ) pathways. The role of the immune response and inflammation (HLA-DRB5/DRB1 , INPP5D , MEF2C ) already implied by previous work (CR1, TREM2) is reinforced, as are the importance of cell migration (PTK2B), lipid transport and endocytosis (SORL1 ). New hypotheses have also emerged related to hippocampal synaptic function (MEF2C , PTK2B), the cytoskeleton and axonal transport (CELF1 , NME8, CASS4) as well as myeloid and microglial cell functions (INPP5D).

All this reinforces the idea that there are several paths to Alzheimer's, and no single treatment approach is likely to be successful.

http://www.eurekalert.org/pub_releases/2013-10/bumc-eng102513.php

[3586] Lambert, J-C., Ibrahim-Verbaas C. A., Harold D., Naj A. C., Sims R., Bellenguez C., et al.
(2013).  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.
Nature Genetics. 45(12), 1452 - 1458.

ADAM10 mutations increase risk of Alzheimer's

Mouse studies have found that two mutations in a gene called ADAM10 (which codes for an enzyme involved in processing the amyloid precursor protein) impaired the folding of the gene, resulting in an increase in toxic amyloid-beta, and reduced neurogenesis in the hippocampus. Previous research had found that either of these mutations was associated with an increased risk of Alzheimer’s in seven families with the late-onset form of the disease.

The finding suggests that increasing ADAM10 activity might be a potential therapeutic approach.

http://www.eurekalert.org/pub_releases/2013-09/mgh-sct092413.php

[3610] Suh, J., Choi S H., Romano D. M., Gannon M. A., Lesinski A. N., Kim D Y., et al.
(2013).  ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function.
Neuron. 80(2), 385 - 401.

TREM2 gene variant has dramatic effect on brain atrophy

Back in January 2013, a study (initially involving 2261 Icelanders, but then repeated on data from the U.S., Norway, the Netherlands, and Germany) reported on a rare genetic variant (TREM2) that nearly trebled Alzheimer’s risk. The variant was found in 0.46% of controls aged 85+. Carriers (aged 85-100) without Alzheimer’s also had poorer cognitive function than non-carriers.

TREM2 is thought to have an anti-inflammatory role, and so it’s thought that this rare mutation reduces its effectiveness.

In a more recent study, brain scans of 478 older adults (average age 76), of whom 100 had Alzheimer's, 221 had MCI and 157 were healthy controls, found that those carrying the TREM2 mutation lost 1.4-3.3% more of their brain tissue than non-carriers, and twice as fast. The loss appeared to be concentrated in the temporal lobe and hippocampus. Those carrying the TREM2 mutation may develop the disease three years earlier than expected.

http://www.eurekalert.org/pub_releases/2013-10/uosc-gml101513.php

[3581] Jonsson, T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P. V., Snaedal J., et al.
(2013).  Variant of TREM2 Associated with the Risk of Alzheimer's Disease.
New England Journal of Medicine. 368(2), 107 - 116.

Rajagopalan, P., Hibar, D.P., & Thompson, P.M. (2013). TREM2 and neurodegenerative disease. The New England Journal of Medicine, 369(16), 1564-1567. Published online Oct. 16, 2013; doi:10.1056/NEJMc1306509

Related News

A study in which 64 sedentary older adults (aged 60-88) participated in a 12-week exercise program found that those who engaged in high-intensity interval training (HIIT) saw an improvement of up to 30% in memory performance while participants who engaged in moderate-intensity aerobic exercise s

A study involving 30 previously physically inactive older adults (aged 61-88) found that a three-month exercise program reversed some brain atrophy.

A long-running study following 387 Australian women found that regular exercise in middle age was the best lifestyle change they could make to prevent cognitive decline in their later years.

A large study, involving nearly 14,000 older adults (50+) participating in the 2006 Health and Retirement Study, found that weaker handgrip strength was associated with a greater risk of developing cognitive impairment, especially severe impairment, over the eight-year study period.

Data from the long-running Rush Memory and Aging Project, involving 960 participants who completed a food frequency questionnaire from 2004 to 2013, found that those who ate one daily serving of green, leafy vegetables had a slower rate of cognitive decline than people who rarely or never ate th

A study involving 99 healthy older adults found that levels of monounsaturated fatty acids were associated with cognitive performance and the organization of the brain's attention network.

Data from 915 older adults (mean age 81.4) participating in the very long-running Rush Memory and Aging Project, has found that those who reported eating seafood less than once a week showed greater cognitive decline compared to those who ate at least one seafood meal per week.

Data from the Canadian Longitudinal Study on Aging, involving 8,574 middle-aged and older adults (aged 45-85), has found that those who ate more vegetables and fruits and more nuts and pulses (such as lentils and beans) scored higher on tests of verbal fluency.

Analysis of data from the Age-Related Eye Disease Study (AREDS) and AREDS2, involving a total of around 8,000 older adults, has found that those with the greatest adherence to the Mediterranean diet had the lowest risk of cognitive impairment.

A 10-year study involving 19,887 middle-aged and older Americans, who completed surveys every two years about their health and lifestyle, has found that those who had a drink or two a day tended to show less cognitive decline, compared to non-drinkers.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news
Error | About memory

Error

The website encountered an unexpected error. Please try again later.